Identification of Ghrelin Receptor Blocker, D-[Lys3] GHRP-6 as a CXCR4 Receptor Antagonist
<p>[D-Lys3]-Growth Hormone Releasing Peptide-6 (DLS) is widely utilized <i>in vivo</i> and <i>in vitro</i> as a selective ghrelin receptor (GHS-R) antagonist. Unexpectedly, we identified that DLS also has the ability to block CXCL12 binding and activity through CXCR4 on...
Main Author: | Kalpesh Patel, Vishwa Deep Dixit, Jun Ho Lee, Jie Wan Kim, Eric M. Schaffer, Dzung Nguyen, Dennis D. Taub |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2012-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v08p0108.htm |
Similar Items
-
The GHS-R Blocker D-[Lys3] GHRP-6 Serves as CCR5 Chemokine Receptor Antagonist
by: Kalpesh Patel, Vishwa Deep Dixit, Jun Ho Lee, Jie Wan Kim, Eric M. Schaffer, Dzung Nguyen, Dennis D. Taub
Published: (2012-01-01) -
Effects of peripheral administration of ghrelin antagonist [D-Lys<sup>3</sup>]-GHRP-6 on growth performance and blood biochemical indices in broiler chickens
by: H. Aghdam Shahryar, et al.
Published: (2016-02-01) -
Ablations of ghrelin and ghrelin receptor exhibit differential metabolic phenotypes and thermogenic capacity during aging.
by: Xiaojun Ma, et al.
Published: (2011-01-01) -
[Clinical value of neuropeptides GHRH and GHRP]
by: Savage, M, et al.
Published: (1996) -
LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity
by: Xuehan Lu, et al.
Published: (2021-08-01)